Nanotechnology + IMMUNOTECHNOLOGY + Biosensors = Nanoimmunotech
HEATSENS® disruptive technology is based on the heat generated by gold nanoprisms. The technology is characterized by greater specificity, greater sensitivity and reduced analysis time, resulting in greater flexibility and lower costs.
If you need to improve your immunoassay or point of care device sensitivity, our R&D department can give you advise on how to apply our nanoparticles and/or our oriented bioconjugation method.
Nanoimmunotech will be part of the industrial advisory committee for a new European project led by ICMA researchers to fight against cancer and heritage pathologies.
We are delighted to present you HEATSENS® 1100 Microfluidic Strip Reader.